Tissue Source AmnioCyteTM TM AmnioCyte Plus PolyCyte …Placenta Placenta Umbilical Cord Umbilical...

transcript

Product Portfolio

R e v o l u t i o n a r y • R e g e n e r a t i v e • T h e r a p e u t i c

Tissue Source

Products

Fetuin-A

Interleukin 37

Macrophage Colony Stimulating Factor

Serpin A4

Syndecan - 4

Bone Morphogenic Protein - 7

Complement Component 5a

Fibroblast Growth Factor

Platelet Derived Growth Factor - AA

Thrombospondin - 2

Adhesion G Protein

Collagen 1, 2, 3

Elastin

Fibronectin

Hyaluronic Acid

Cystatin - B

Galectin - 9

Granulysin

Lipocalin - 2

Intracellular Adhesion Molecule 1

PlacentaPlacenta Umbilical CordUmbilical Cord

AmnioCyteAmniotic Fluid Allograft

AmnioCyte PlusAmniotic Matrix Allograft

TM TM TM TM

CoreCytePolyCyte Wharton’s Jelly Allograft Wharton’s Jelly Allograft

Mesenchymal Stem Cells (MSC)

Biologically Young Source

Viable MSC Cell Count

Positive Expression of CD73

Lack Expression of CD14

Lack Expression of HLA-DR

Viable MSC: Plastic Adherent

Predictive Biotech’s products are processed from donated human tissue from full term deliveries in accordance with FDA guidelines. Predictive Biotech’s products are regulated as a human cell, tissue, or cellular or tissue-based products (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act. All of Predictive Biotech’s human cell and tissue products are intended for homologous use.

Number of check marks reflect relative factor amounts as compared to other Predictive Biotech products. All data represented on this grid is informed by either or all available literature, external validation and internal testing. Empty data fields indicate quantities either found in trace amounts, or quantities not specified in literature. Citations and references on file with Predictive Biotech.

MKT-0025, 28 May 2019

Tissue Source AmnioCyteTM TM AmnioCyte Plus PolyCyte …Placenta Placenta Umbilical Cord Umbilical...

Documents